HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability
Go back to HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability| Craft Brewers Alliance, Inc. (NASDAQ: HOOK) | Delayed: 0.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $10.17 | |||
| Open | $0.84 | 52 Week Low | $5.08 | |||
| Day High | $0.84 | P/E | 1.65 | |||
| Day Low | $0.84 | EPS | $0.51 | |||
| Volume | 3,881,920 | |||||
